Aspirin can stop cancer spreading
Taking a daily dose of aspiring could reduce the chance of dying from cancer, according to vital research.
The three new studies published by The Lancet add to mounting evidence of the drug's anti-cancer effects.
It reveals that taking daily low-dose pills for just three years can reduce your risk of cancer by about a quarter. This risk of dying from cancer is but by 15 per cent - and by 37 per cent for those who take aspiring for longer than five years.
For some time scientists have known that aspiring protects against certain types of cancer, particularly those affecting the bowel and throat.
But this is the first time they have revealed it could also treat illness by preventing tumours spreading to other organs, which is often fatal.
Professor Peter Rothwell said extra research need to be carried out 'urgently'.